{"id":"NCT00383019","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).","officialTitle":"A 8-WEEK, RANDOMIZED, DOUBLE-MASKED, PARALLEL GROUP, PHASE III STUDY COMPARING THE EFFICACY AND SAFETY OF XALACOM AND XALATAN IN PATIENTS WITH PRIMARY OPEN ANGLE GLAUCOMA (POAG) OR OCULAR HYPERTENSION (OH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11-14","primaryCompletion":"2007-10-01","completion":"2007-10-01","firstPosted":"2006-10-02","resultsPosted":"2009-05-27","lastUpdate":"2021-09-08"},"enrollment":300,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"Xalatan","otherNames":[]},{"type":"DRUG","name":"Xalacom","otherNames":[]}],"arms":[{"label":"Xalatan","type":"EXPERIMENTAL"},{"label":"Xalacom","type":"EXPERIMENTAL"}],"summary":"This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan in Japanese patients with POAG or OH, in order to show superiority of Xalacom over Xalatan in efficacy and similarity of safety between Xalacom and Xalatan.","primaryOutcome":{"measure":"Change of Intraocular Pressure (IOP) From Baseline to Week 8","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"KP2035 Group","deltaMin":-2.59,"sd":null},{"arm":"Xalatan Group","deltaMin":-1.62,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":54,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6641050&StudyName=A%20Study%20Comparing%20Xalacom%20And%20Xalatan%20In%20Patients%20With%20Primary%20Open%20Angle%20Glaucoma%20%28POAG%29%20Or%20Ocular%20Hypertension%20%28OH%29.%0A"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":144},"commonTop":["Eye irritation","Nasopharyngitis","Punctate keratitis","Conjunctival hyperaemia","Eczema"]}}